Keyphrases
Immune Checkpoint Inhibitors
100%
Lung Adenocarcinoma
100%
Anemia
100%
Chromosomal Abnormalities
100%
Pure Red Cell Aplasia
100%
Prednisolone
50%
Pembrolizumab
50%
Immune-related
50%
Older Men
25%
Adverse Events
25%
Recurring
25%
2-cycles
25%
Anticancer Agents
25%
Erythroblasts
25%
Treatment History
25%
Cytotoxic Agents
25%
Carboplatin
25%
Hypoplasia
25%
Monotherapy
25%
Myelosuppression
25%
Immune-related Adverse Events
25%
Combined Therapy
25%
Advanced Lung Adenocarcinoma
25%
Pemetrexed
25%
Bone Marrow Biopsy
25%
Red Blood Cell Transfusion
25%
Medicine and Dentistry
Immune Checkpoint Inhibitor
100%
Chromosome Aberration
100%
Anemia
100%
Lung Adenocarcinoma
100%
Pure Red Cell Aplasia
100%
Prednisolone
50%
Pembrolizumab
50%
Immunity
50%
Adverse Event
25%
Anticarcinogen
25%
Monotherapy
25%
Cytotoxic Agent
25%
Carboplatin
25%
Hypoplasia
25%
Bone Marrow Biopsy
25%
Combined Therapy
25%
Pemetrexed
25%
Immune-Related Adverse Events
25%
Erythroblast
25%
Bone Marrow Suppression
25%
Erythrocyte Transfusion
25%